However, the FDA is giving compounders a 60- or 90-day wind-down period, depending on the type of compounding facility, to avoid unnecessary disruption to patient treatment and to help facilitate an orderly transition. The agency intends to exercise enforcement discretion (i.e., not take enforcement action) until April 22 for compounding performed by state-licensed pharmacies and physicians, and until May 22 for FDA-registered outsourcing facilities
DEXA showed lean-mass preservation (learn how DEXA measures muscle vs
Gastric bypass doesn't have reflux
They are not magic solutions, require long-term commitment (both financial and behavioral), often cause side effects that affect quality of life, and may not work for everyone
A retrospective cohort study, found that 4,340 out of 7,043 (62%) of patients taking phentermine for short-term use experienced at least 3% weight loss in 3 months